Can you help advance cell therapy and regenerative medicine programs?
If so, we have an audience of stem cell entrepreneurs, innovators and disruptors looking to move their business forward.
'Very well organised conference with excellent networking facilities'
Nico Verlinden, Perkin Elmer
‘Good exhibition area, good traffic’
Rudolf Schmitt, GE Healthcare Europe
‘Interesting talks and high level discussions with good networking’
Markus Sack, RWTH Aachen University
At the 2014 World Drug Safety Congress Americas Susan Duke, GSK, gave a presentation on “Implementing benefit-risk thinking and quantification into the culture and processes ...
Disorder-specific impairments and treatment-induced effects on cognitive function Diabetes mellitus is defined by high blood glucose concentrations and the body’s inability to regulate these concentrations ...
Innovation and strategy for pharmaceutical, biotech and R&D